Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in China
10 of 19 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleThe Application of T1 Mapping in Real-World
- Where
- Beijing
- People
- 2,000
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07354646 - No phaseTaking peopleA Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
- Where
- Beijing, Changchun, Chengdu, Dalian, Guangzhou, Hangzhou, Harbin, Jiazhuang, Jinan, Shanghai, Suzhou, Xi'an, Zhengzhou
- Age
- 18 years and over
- People
- 500
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361289 - No phaseNot yet taking people in ChinaEvaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy
- Where
- Shanghai
- Age
- 18 years and over
- People
- 800
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07846059 - No phaseTaking peopleA Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 3,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06775665 - No phaseNot yet taking people in ChinaA Real-world HCM-cohort Trial
- Where
- Xi'an
- People
- 3,000
- Run by
- Xijing Hospital
See details and how to joinNCT07638033 - No phaseTaking peopleValsalva SBP Drop and LVOT Obstruction
- Where
- Shanghai
- Age
- 18 years and over
- People
- 800
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07483125 - No phaseTaking peopleAI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 15,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07263204 - No phaseEnrolling by invitationEvaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 200
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06683872 - No phaseTaking peopleChina Structural Ventricular Arrhythmias Registry
- Where
- Beijing
- People
- 2,000
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT03821051 - No phaseTaking peopleThe Chinese Hypertrophic Cardiomyopathy Study(CHCS)
- Where
- Beijing
- People
- 3,000
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT02696135